Stock listing
NASDAQ:BOLD Audentes Therapeutics Inc Stock
Follow Audentes Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:BOLD
$59.97 USD
Close on Jan 16, 2020 · No longer trades
- Lowest – highest close
- $14.11 – $60.00 USDSince Jul 20, 2016 · lowest Sep 14, 2016 · highest Jan 6, 2020
Delisted NASDAQ:BOLD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BOLD
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Audentes Therapeutics Inc on 6ix
- Decks
- 10 decks · latest Oct 9, 2019
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 10, 2026 · Before open | −0.4% |
| Quarter to Jun 30, 2026 | Aug 7, 2026 | −0.7% |
| Quarter to Mar 31, 2026 | May 8, 2026 · Before open | −5.9% |
| Quarter to Dec 31, 2025 | Mar 26, 2026 | −1.8% |
| Quarter to Sep 30, 2025 | Nov 5, 2025 · Before open | −3.1% |
| Quarter to Jun 30, 2025 | Aug 5, 2025 · Before open | −1.7% |
| Quarter to Mar 31, 2025 | May 9, 2025 · Before open | −4.0% |
| Quarter to Dec 31, 2024 | Mar 27, 2025 | −1.3% |
| Quarter to Sep 30, 2024 | Nov 7, 2024 · After close | +5.4% |
| Quarter to Jun 30, 2024 | Aug 12, 2024 · After close | +2.8% |
All 12 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2024 | May 13, 2024 · Before open | +10.8% |
| Quarter to Dec 31, 2023 | Feb 28, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 24th International Annual Congress of the World Muscle Society (WMS) Annual Meeting 2019 | Conference | 24 slides | Oct 9, 2019 |
| Technical Presentation (May 2019) | Technical | 29 slides | May 1, 2019 |
| Technical Presentation (October 2018) | Technical | 20 slides | Oct 5, 2018 |
| Technical Presentation (May 2018) | Technical | 16 slides | May 16, 2018 |
| Technical Presentation (January 2018) | Technical | 21 slides | Jan 4, 2018 |
| Investor Presentation (September 2017) | Investor deck | 33 slides | Sep 27, 2017 |
| Technical Presentation (September 2017) | Technical | 23 slides | Sep 27, 2017 |
| Cowen 37th Annual Health Care Conference 2017 | Conference | 36 slides | Mar 7, 2017 |
| Investor Presentation (November 2016) | Investor deck | 34 slides | Nov 29, 2016 |
| Investor Presentation (September 2016) | Investor deck | 34 slides | Sep 28, 2016 |
Cap table
Built by 6ix from Audentes Therapeutics Inc’s releases
- Common shares
- 23,108,935
- Fully diluted
- 23,108,935
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 23,108,935 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 23,108,935 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Samuel D Isaly Other companies: Synlogic Inc (Director · Aug 28, 2017 – Aug 28, 2017 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – Jul 24, 2017 · Past); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Mar 15, 2017 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Dec 30, 2016 · Past); Roka Bioscience Inc (Director · Sep 21, 2016 – Sep 21, 2016 · Past); Loxo Oncology Inc (Director · Aug 10, 2016 – Dec 8, 2017 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Corvus Pharmaceuticals, Inc. (Director · May 18, 2016 – Jun 23, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 11, 2016 – May 11, 2016 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Mar 27, 2017 · Past); Otonomy Inc (Director · Nov 17, 2015 – Nov 25, 2015 · Past); Dimension Therapeutics (Director · Oct 27, 2015 – Oct 27, 2015 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Jul 6, 2015 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Aug 31, 2017 · Past); Intercept Pharmaceuticals Inc (Director · Apr 9, 2013 – Jul 17, 2015 · Past); Supernus Pharmaceuticals, Inc. (Director · May 4, 2012 – May 4, 2012 · Past); Anthera Pharmaceuticals Inc (Director · May 9, 2011 – Jan 30, 2013 · Past); Amarin Corporation plc (Director · Jan 1, 2011 – Sep 4, 2012 · Past); NxStage Medical Inc (Director · Jul 23, 2008 – Dec 9, 2010 · Past); Albireo Pharma Inc (Director · Feb 12, 2008 – Jun 9, 2009 · Past); Aryx Therapeutics Inc (Director · Nov 7, 2007 – Nov 13, 2007 · Past); Insulet Corporation (Director · May 14, 2007 – May 14, 2007 · Past); Volcano Corp (Director · Jun 14, 2006 – Jun 20, 2006 · Past); Given Imaging Ltd (Director · May 24, 2006 – May 24, 2006 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – May 31, 2006 · Past) | Director · Jul 19, 2016 – Jul 19, 2016 · Past |
| Jennifer Jarrett Other companies: Damora Therapeutics, Inc. (President and Chief Executive Officer in March 2026, Board Director · Since at least Mar 30, 2026); Sagimet Biosciences Inc. - Series A (Board Member · Since at least Aug 1, 2024); Zura Bio Limited (Director · Since at least Mar 20, 2023); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 25, 2018); Arcus Biosciences, Inc. (Chief Operating Officer · Since at least Mar 14, 2018); Radius Health, Inc. (Director · May 18, 2022 – Aug 15, 2022 · Past); Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Arena Pharmaceuticals Inc (Director · Jun 13, 2017 – Mar 11, 2022 · Past); Medivation Inc (Chief Financial Officer · Apr 7, 2016 – Sep 28, 2016 · Past) | Director · Jun 12, 2017 – Jan 15, 2020 · Past |
| Kush M. Parmar Other companies: Entrada Therapeutics, Inc. (Managing Partner, 5am Ventures (Board Chairman) · Since at least Oct 28, 2021); Rallybio Corporation (Director · Jul 28, 2021 – May 15, 2024 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – Jun 14, 2022 · Past); 5 01 Acquisition Corp (Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Arvinas, Inc. (Director · Sep 26, 2018 – Sep 24, 2019 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past); Scpharmaceuticals Inc (Director · Nov 16, 2017 – Jun 19, 2018 · Past) | Director · Jul 19, 2016 – Jun 8, 2018 · Past |
| Natalie Holles Other companies: LeonaBio, Inc. (Board Member | Chief Executive Officer · Since at least May 5, 2026); Aura Biosciences, Inc. (Chief Executive Officer and President and member of the Board · Since at least Apr 30, 2026); Third Harmonic Bio Inc. (CEO, Director · Since at least Sep 14, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Allakos Inc (Director · Dec 21, 2020 – May 25, 2021 · Past); Rubius Therapeutics Inc (Director · Mar 19, 2019 – May 12, 2022 · Past); Hyperion Therapeutics Inc (SVP, Business Development · Jun 24, 2013 – May 7, 2015 · Past) | President and COO · Jul 19, 2016 – Jan 15, 2020 · Past |
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · Dec 11, 2017 – Jan 15, 2020 · Past |
| Scott Morrison Other companies: Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 6, 2022); Zai Lab Ltd. (Board Member · Since at least Oct 13, 2021); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); IDEAYA Biosciences, Inc. (Director | Partner, Ernst & Young (retired) · Since at least May 22, 2019); Corvus Pharmaceuticals, Inc. (Director · Since at least Mar 22, 2016); Global Blood Therapeutics Inc (Director · Jan 1, 2016 – Oct 5, 2022 · Past) | Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| Thomas Woiwode Other companies: Tempest Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 17, 2022 · Past); Aligos Therapeutics, Inc. (Director · Oct 15, 2020 – Jun 23, 2022 · Past); Passage Bio, Inc. (Director · Feb 27, 2020 – May 25, 2023 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Aug 25, 2021 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Jun 15, 2018 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – May 12, 2021 · Past) | Director · Jul 19, 2016 – Aug 24, 2016 · Past |
| Edward R. Conner Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since Apr 22, 2026); Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past) | SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past |
| Louis G Lange Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jul 1, 2013 · Past); Maxygen Inc (Director · May 27, 2010 – Jun 6, 2012 · Past) | Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| Stephen P Squinto Other companies: Chemomab Therapeutics Ltd. (Director · Mar 16, 2021 – Apr 19, 2021 · Past); Compass Therapeutics, Inc. (Director · Jun 17, 2020 – Feb 18, 2022 · Past); Passage Bio, Inc. (Head of Research and Dev, Director · Feb 27, 2020 – Feb 27, 2020 · Past); SpringWorks Therapeutics Inc (Director · Mar 29, 2019 – May 19, 2022 · Past); Alexion Pharmaceuticals Inc (EVP, Chief Global Ops. Officer · Jan 9, 2006 – Oct 27, 2014 · Past) | Director · Jul 19, 2016 – Oct 8, 2017 · Past |
All 19 people
| Person | Seat |
|---|---|
| Julie Anne Smith Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 3, 2020); Exelixis, Inc. (Director · Since at least Sep 22, 2016); Raptor Pharmaceutical Corp (President and CEO, Director · Sep 10, 2012 – Oct 24, 2016 · Past) | Director · Dec 12, 2016 – Jan 15, 2020 · Past |
| Matthew R Patterson Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past) | Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| Thomas P Soloway Other companies: Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Satsuma Pharmaceuticals Inc (Director · Jul 2, 2020 – Jun 8, 2023 · Past); Paratek Pharmaceuticals Inc (EVP, Chief Operating Officer · Jan 30, 2009 – Jul 15, 2013 · Past) | Executive Vice President, CFO · Jul 19, 2016 – Jan 15, 2020 · Past |
| Mark Meltz Other companies: Lyell Immunopharma, Inc. (General Counsel and Corporate Secretary · Since at least Jun 9, 2025); Kinnate Biopharma Inc (COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past) | SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past |
| Thomas J. Schuetz Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past) | Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| David Nagler Other companies: Aryx Therapeutics Inc (V.P.,Corp. Affairs & Sect. · Nov 7, 2007 – Feb 25, 2010 · Past) | SVP, HR & Corp. Affairs · Jul 19, 2016 – Jun 20, 2018 · Past |
| Suyash Prasad Other companies: Taysha Gene Therapies, Inc. (CMO and Head of R&D · Sep 23, 2020 – Jul 5, 2022 · Past) | Senior VP & Chief Med Officer · Jul 19, 2016 – Jun 5, 2019 · Past |
| John T Gray | SVP, Chief Scientific Officer · Jul 19, 2016 – Sep 28, 2018 · Past |
| Mary Newman | SVP, Regulatory Affairs · Jul 19, 2016 – Nov 15, 2018 · Past |
Log in to ask 6ix AI your own questions about Audentes Therapeutics Inc.